Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001161697-19-000147
Filing Date
2019-04-26
Accepted
2019-04-26 12:09:17
Documents
3
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDMENT NO. 1 TO ANNUAL REPORT FOR 09-30-2018 form_10-k.htm 10-K/A 9527
2 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3972
3 GRAPHIC angiosoma_logo.jpg GRAPHIC 8426
  Complete submission text file 0001161697-19-000147.txt   26334
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-55072 | Film No.: 19770474
SIC: 2834 Pharmaceutical Preparations